Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
MeritCare Clinical Research
mi
from
Fargo, ND
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
MeritCare Clinical Research
mi
from
Fargo, ND
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Remington Davis Inc.
mi
from
Columbus, OH
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Remington Davis Inc.
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Idaho Falls Infectious Disease, PLLC
mi
from
Idaho, ID
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Idaho Falls Infectious Disease, PLLC
mi
from
Idaho, ID
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Metropolitan Gastroentrology Group
mi
from
Chevy Chase, MD
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Metropolitan Gastroentrology Group
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Tufts University School of Medicine
mi
from
Boston, MA
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Tufts University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
mi
from
Keego Harbor, MI
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
mi
from
Keego Harbor, MI
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Mercury Street Medical Group - Research Group
mi
from
Butte, MT
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Mercury Street Medical Group - Research Group
mi
from
Butte, MT
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
University of Calgary, Foothills Medical Center
mi
from
Calgary,
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
University of Calgary, Foothills Medical Center
mi
from
Calgary,
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Central Florida Internists
mi
from
Saint Cloud, FL
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Central Florida Internists
mi
from
Saint Cloud, FL
Click here to add this to my saved trials
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated:  12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Study of CB-183,315 in Participants With Clostridium Difficile Infection
A Randomized, Double-Blinded, Active-Controlled, Dose Ranging Study of CB-183,315 in Patients With Clostridium Difficile Infection.
Status: Enrolling
Updated: 12/31/1969
Missouri Baptist Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study of Cimzia for the Treatment of Ulcerative Colitis
Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Study of Cimzia for the Treatment of Ulcerative Colitis
Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Cimzia for the Treatment of Ulcerative Colitis
Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Study of Cimzia for the Treatment of Ulcerative Colitis
Certolizumab Pegol for the Treatment of Moderate to Severe Ulcerative Colitis: An Open Label Study
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (201102127)
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (201102127)
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (201102127)
Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk (201102127)
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Status: Enrolling
Updated:  12/31/1969
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Neutrophil Extracellular Trap Formation in Newborn Infants at Risk for Necrotizing Enterocolitis
Status: Enrolling
Updated: 12/31/1969
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Mt. Graham Regional Medical Center
mi
from
Safford, AZ
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Mt. Graham Regional Medical Center
mi
from
Safford, AZ
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Tempe St. Luke's Hospital
mi
from
Tempe, AZ
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Tempe St. Luke's Hospital
mi
from
Tempe, AZ
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Swedish Medical Center and SurgOne P.C.
mi
from
Englewood, CO
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Swedish Medical Center and SurgOne P.C.
mi
from
Englewood, CO
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Munroe Regional Hospital
mi
from
Ocala, FL
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Munroe Regional Hospital
mi
from
Ocala, FL
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
St Mary's Hospital
mi
from
Hobart, IN
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
St Mary's Hospital
mi
from
Hobart, IN
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Livingston Hospital and Healthcare Services, Inc. CAH
mi
from
Salem, KY
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Livingston Hospital and Healthcare Services, Inc. CAH
mi
from
Salem, KY
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
The Surgeons Group of Baton Rouge
mi
from
Baton Rouge, LA
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
The Surgeons Group of Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Allegan Surgical Associates
mi
from
Allegan, MI
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Allegan Surgical Associates
mi
from
Allegan, MI
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Crossville Medical Group
mi
from
Crossville, TN
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Crossville Medical Group
mi
from
Crossville, TN
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Ihde Surgical Group, PA
mi
from
Arlington, TX
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Ihde Surgical Group, PA
mi
from
Arlington, TX
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Master Center for Minimally Invasive Surgery
mi
from
Southlake, TX
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Master Center for Minimally Invasive Surgery
mi
from
Southlake, TX
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Utah County Surgical Associates
mi
from
Provo, UT
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Utah County Surgical Associates
mi
from
Provo, UT
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
Reston Hospital
mi
from
Reston, VA
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
Reston Hospital
mi
from
Reston, VA
Click here to add this to my saved trials
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center
mi
from
Houston, TX
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
Prospective Outcome Evaluation of Transoral Incisionless Fundoplication (TIF) for the Treatment of Gastroesophageal Reflux Disease (GERD): The TIF Registry Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Medical Institution
mi
from
Philadelphia, PA
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Medical Institution
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated:  12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated: 12/31/1969
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated:  12/31/1969
Johannes Gutenberg - University of Mainz
mi
from
Mainz,
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
In Vivo Endomicroscopy (EM) for Improved Diagnosis of Barrett's Esophagus (BE) and Associated Neoplasia: A Multicenter Randomized Controlled Trial of Diagnostic Yield and Clinical Impact
Status: Enrolling
Updated: 12/31/1969
Johannes Gutenberg - University of Mainz
mi
from
Mainz,
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
SurgOne PC
mi
from
Englewood, CO
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
SurgOne PC
mi
from
Englewood, CO
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Ohio State University Hospital
mi
from
Columbus, OH
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Ohio State University Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Oregon Clinic
mi
from
Portland, OR
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Oregon Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Reston Surgical Associates
mi
from
Reston, VA
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Reston Surgical Associates
mi
from
Reston, VA
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
A Randomized Controlled Trial Comparing Transoral Incisionless Fundoplication (TIF) Using EsophyX With Sham Procedure for the Treatment of PPI Dependent GERD Compared With Sham and Placebo Controls
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials